NEOADJUVANT IMMUNOTHERAPY
Clinical trials for NEOADJUVANT IMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Less lung surgery after immunotherapy? study tests new approach
Disease control Not yet recruitingThis study compares two types of lung cancer surgery for patients who have already responded well to immunotherapy. It aims to see if a less extensive surgery, which removes less lung tissue, is as effective at controlling cancer as the standard, more extensive surgery. The goal …
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for lung cancer patients: skipping chemo before surgery?
Disease control Not yet recruitingThis study tests a chemotherapy-free combination treatment given before surgery for certain types of operable lung cancer. It aims to shrink tumors using targeted radiation, immunotherapy, and a drug that blocks tumor blood vessels, hoping to improve surgical outcomes and reduce …
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug tested to stop rare skin cancer from spreading
Disease control Not yet recruitingThis study is testing whether a drug called cemiplimab, given before surgery, can help control early-stage Merkel cell carcinoma, a rare and aggressive skin cancer. It will involve about 135 adults whose main tumor has been removed but who are still waiting for a lymph node biops…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC